Vorinostat in Treating Patients With Locally Recurrent or Metastatic Cancer of the Urothelium
Condition(s):Localized Transitional Cell Cancer of the Renal Pelvis and Ureter; Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter; Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter; Regional Transitional Cell Cancer of the Renal Pelvis and Ureter; Transitional Cell Carcinoma of the BladderLast Updated:February 13, 2015Terminated